Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

Details for Australian Patent Application No. 2004223855 (hide)

Owner The Government of the United States of America, as represented by The Secretary of The Department of Health and Human Services

Inventors Lal, Renu B.; Owen, Sherry M.

Agent Griffith Hack

Pub. Number AU-B-2004223855

PCT Pub. Number WO2004/085466

Priority 60/458,880 28.03.03 US

Filing date 26 March 2004

Wipo publication date 7 October 2004

Acceptance publication date 17 June 2010

International Classifications

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/085466 Priority application(s): WO2004/085466

17 June 2010 Application Accepted

  Published as AU-B-2004223855

14 October 2010 Standard Patent Sealed

17 March 2011 Corrigenda

  Applications Accepted - Name Index Under the name The Government of the United States of America, as represented by The Secretary of The Department of Health and Human Services, Application No. 2004223855, under (INID) 71 correct the applicant name to The Government of the United States of America, as represented by The Secretary of The Department of Health and Human Services, Centers for Disease Control and Prevention

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004223866-Xanthones, thioxanthones and acridinones as DNA-PK inhibitors

2004223847-Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid